The enduring conflict in Eastern Europe has directly hit Indian business interests operating on Ukrainian soil. On October 4, an intense aerial bombardment targeted the primary production complex of Kusum Pharma located in the northeastern city of Sumy, situated roughly 23 kilometres from the Russian frontier. An estimated eight unmanned aerial vehicles converged on the pharmaceutical compound, reducing its central structure to debris and sending dense columns of black smoke billowing into the sky. The strike claimed the life of an engineer on site and left multiple workers injured, while inflicting financial devastation assessed at approximately 500 crore rupees.
Weekend Timing Prevented Massive Loss of Life
The manufacturing establishment is helmed by 57-year-old entrepreneur Rajiv Gupta, originally hailing from Bharatpur in Rajasthan. He was stationed in the capital city of Kyiv when the aerial strike unfolded, remaining entirely out of harm's way. His cousin, Rajkumar Gupta, explained that the incident coincided with a Sunday, which prevented far greater physical casualties. Because Sunday was a scheduled off-day, only a skeletal crew was on the premises compared to the substantial staffing present on standard workdays. Nevertheless, the physical destruction brought all medicine production to an absolute standstill as local teams began rescue operations and damage evaluations.
Operations Continued Despite Border Proximity and Prior Attacks
Positioned merely 23 kilometres away from Russian territory, the facility had maintained round-the-clock manufacturing throughout the war, seeking to sustain medical supplies despite precarious regional conditions. The site had already endured a strike approximately one year earlier, sustaining substantial financial harm before resuming regular assembly lines. However, the scale of this latest eight-drone barrage has shattered key infrastructure beyond immediate recovery. The obliteration of the facility not only delivers a massive balance-sheet shock to the firm but also raises urgent questions regarding the physical security of Indian professionals managing enterprises across the war zone.
From Medicine Distribution to Manufacturing Scale
Rajiv Gupta ventured into the Ukrainian healthcare sector in 1994, initially establishing a distribution entity that moved pharmaceuticals from India into Ukrainian markets. Recognizing broader regional requirements for affordable therapeutics, he transitioned toward localized production and set up the dedicated factory in Sumy in 2009 under the banner of Kusum Healthcare Private Limited. The venture gradually expanded its therapeutic scope, eventually formulating and packaging more than 50 distinct generic pharmaceutical preparations for vital healthcare needs.
Global Footprint Spanning Nine Nations
While the executive headquarters of the Kusum enterprise operates out of Kyiv, the Sumy location functioned as its primary manufacturing pillar in Ukraine. The enterprise oversees commercial activities across more than nine international jurisdictions, including Kazakhstan, Uzbekistan, Iran, the Philippines, Dubai, the United Arab Emirates, Italy, and the United Kingdom. Within India, the enterprise maintains two functional operating plants, with one base situated in Bhiwadi, Rajasthan, and a second facility functioning at Pithampur in Madhya Pradesh. Rajiv Gupta's immediate household currently resides in London. With the primary factory building in Sumy completely ruined, the company faces prolonged operational disruption across its eastern European distribution pipeline.
